ANDA 88610, held by Chartwell Rx. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 88610 (Phentermine Hydrochloride), held by Chartwell Rx, was first approved by FDA on Jun 4, 1984, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 4, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride37.5MG ยท capsule;oral | Phentermine Hydrochloride | Discontinued |
| Oct 6, 2000 | Supplement 12Manufacturing | Approved | None posted |
| Nov 3, 1998 | Supplement 10Labeling | Approved | None posted |
| Aug 19, 1998 | Supplement 9Labeling | Approved | None posted |
| Apr 8, 1998 | Supplement 8Labeling | Approved | None posted |
| Dec 19, 1997 | Supplement 7Labeling | Approved | None posted |
| Oct 16, 1992 | Supplement 6Manufacturing | Approved | None posted |
| Jun 27, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Jun 27, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Jun 4, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters